Schornstein Alexander's Form 4 filing
Assembly Biosciences, Inc. (ASMB) · filed Nov 26, 2024
- Accession no.
- 0001079973-24-001637
- Filed
- Nov 26, 2024
- Trade date
- Nov 22-25, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $372.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schornstein AlexanderCIK 0001999256 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +17,024 | $14.87F2 | +$253,146.88 | 720,137 | Direct | |
| Nov 25, 2024 | Common Stock | PPurchaseAcquired | +2,976 | $15.00F4 | +$44,640 | 723,113 | Direct | |
| Nov 25, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $14.85F6 | +$74,250 | 728,113 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Referenced by the price of 1 transaction in Table I.
- F4
2,976 shares were purchased on November 25, 2024 at $15.00.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Referenced by the price of 1 transaction in Table I.